Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Parasomnias 1Neoplasms 1Fatigue 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Paclitaxel 9Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Cisplatin 8Carboplatin 8Granulocyte Colony-Stimulating Factor 7Etoposide 7Radiotherapy, Intensity-Modulated 6Nivolumab 6Leucovorin 6Filgrastim 6Drug Therapy 6Doxorubicin 6Radiotherapy 5Oxaliplatin 5Fluorouracil 5Docetaxel 5Bevacizumab 5pembrolizumab 4gallium 68 PSMA-11 4Taxes 4Sirolimus 4Rituximab 4Pemetrexed 4Melphalan 4Immunoglobulin G 4Gemcitabine 4Disulfides 4Dexamethasone 4Cytarabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Has results × Melatonin × Clear all
NCT00925899 2017-04-20

Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer

Bispebjerg Hospital

Phase 2/3 Completed
72 enrolled 11 charts

Fatigue, Neoplasms

NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated
54 enrolled 27 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡